Marimed (MRMD) Enterprise Value (2011 - 2026)
Marimed's (MRMD) quarterly Enterprise Value came in at -$9.8 million in Q1 2026, down 9.47% year-on-year from -$10.9 million in Q1 2025, and up 8.52% on a QoQ basis from -$10.7 million in Q4 2025.
Marimed (MRMD) Enterprise Value (2011 - 2026) Analysis & Trends
Marimed (MRMD) has 16 years of Enterprise Value data on file, last reported at -$9.8 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 9.47% year-over-year to -$9.8 million in Q1 2026; TTM through Mar 2026 was -$9.8 million, a 9.47% decrease from a year earlier, with the FY2025 full-year figure at -$10.7 million, down 18.94% from the prior year.
- Enterprise Value for Q1 2026 stood at -$9.8 million, up from -$10.7 million in the prior quarter.
- Over the last five years, Enterprise Value for MRMD reached as high as -$7.9 million in Q2 2025 and fell as low as -$36.3 million in Q1 2022.
- Historically, Enterprise Value has averaged -$13.9 million across 5 years, with a median of -$11.5 million in 2024.
- On a YoY basis, Enterprise Value climbed as much as 63.9% in 2022 and fell as far as 155.85% in 2022.
- Year by year, Enterprise Value stood at -$11.4 million in 2022, then tumbled by 44.08% to -$16.4 million in 2023, then soared by 44.86% to -$9.0 million in 2024, then declined by 18.94% to -$10.7 million in 2025, then gained by 8.52% to -$9.8 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$9.8 million in Q1 2026, -$10.7 million in Q4 2025, and -$8.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn | -9.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.83 Mn |
| Dec 31, 2025 | -10.75 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Mar 31, 2025 | -8.98 Mn |
| Dec 31, 2024 | -9.03 Mn |
| Sep 30, 2024 | -11.52 Mn |
| Jun 30, 2024 | -11.91 Mn |
| Mar 31, 2024 | -16.92 Mn |
| Dec 31, 2023 | -16.38 Mn |
| Sep 30, 2023 | -15.07 Mn |
| Jun 30, 2023 | -16.33 Mn |
| Mar 31, 2023 | -23.26 Mn |
| Dec 31, 2022 | -11.37 Mn |
| Sep 30, 2022 | -12.87 Mn |
| Jun 30, 2022 | -9.89 Mn |
| Mar 31, 2022 | -36.33 Mn |
| Dec 31, 2021 | -31.50 Mn |
| Sep 30, 2021 | -27.14 Mn |
| Jun 30, 2021 | -18.87 Mn |